MoneyWorks4Me

The sales moved up 29.24% to Rs. 1446.70 millions for the March 2023 quarter as compared to Rs. 1119.40 millions during the year-ago period.Net profit for the quarter ended March 2023 increased significantly by 87.22% to Rs. 543.30 millions from Rs. 290.20 millions.Operating profit surged to 770.90 millions from the corresponding previous quarter of 486.70 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 1446.70 1119.40 29.24 5286.10 5280.60 0.10 5286.10 5280.60 0.10
Other Income 122.20 102.60 19.10 990.00 565.50 75.07 990.00 565.50 75.07
PBIDT 770.90 486.70 58.39 3189.20 2761.70 15.48 3189.20 2761.70 15.48
Interest 0.30 0.20 50.00 1.20 0.90 33.33 1.20 0.90 33.33
PBDT 770.60 486.50 58.40 3188.00 2760.80 15.47 3188.00 2760.80 15.47
Depreciation 62.90 69.50 -9.50 256.50 257.70 -0.47 256.50 257.70 -0.47
PBT 707.70 417.00 69.71 2931.50 2503.10 17.11 2931.50 2503.10 17.11
TAX 164.40 126.80 29.65 588.90 624.40 -5.69 588.90 624.40 -5.69
Deferred Tax -15.20 0.10 -15300.00 -76.90 8.20 -1037.80 -76.90 8.20 -1037.80
PAT 543.30 290.20 87.22 2342.60 1878.70 24.69 2342.60 1878.70 24.69
Equity 151.80 151.60 0.13 151.80 151.60 0.13 151.80 151.60 0.13
PBIDTM(%) 53.29 43.48 22.56 60.33 52.30 15.36 60.33 52.30 15.36
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..